Estetrol (E4): the new estrogenic component of combined oral contraceptives

Giovanni Grandi; Maria Chiara Del Savio; Agnaldo Lopes da Silva-Filho; Fabio Facchinetti

doi:10.1080/17512433.2020.1750365

Estetrol (E4): the new estrogenic component of combined oral contraceptives

Expert Rev Clin Pharmacol. 2020 Apr;13(4):327-330. doi: 10.1080/17512433.2020.1750365. Epub 2020 Apr 7.

Authors

Giovanni Grandi¹, Maria Chiara Del Savio¹, Agnaldo Lopes da Silva-Filho², Fabio Facchinetti¹

Affiliations

¹ Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia , Modena, Italy.
² Departamento de Ginecologia e Obstetricia da UFMG, Federal University of Minas Gerais , Belo Horizonte, Brazil.

PMID: 32238069
DOI: 10.1080/17512433.2020.1750365

No abstract available

Keywords: Hormonal contraception; cardiovascular risks; combined hormonal contraceptives; drospirenone; estetrol; estradiol; ethinyl-estradiol; hemostasis; levonorgestrel; metabolism; venous thromboembolic events.

Publication types

Comparative Study
Editorial

MeSH terms

Contraceptives, Oral, Combined / administration & dosage*
Contraceptives, Oral, Combined / adverse effects
Contraceptives, Oral, Combined / pharmacology
Estetrol / administration & dosage*
Estetrol / adverse effects
Estetrol / pharmacology
Female
Humans

Substances

Contraceptives, Oral, Combined
Estetrol